What is the recommended dosage and administration of iron bisglycinate (elemental iron) for patients requiring iron supplementation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Bisglycinate Supplementation: Dosage and Administration Guidelines

For patients requiring iron supplementation, iron bisglycinate should be administered at a dose of 60-120 mg of elemental iron given as a single morning dose on alternate days to maximize absorption and minimize side effects.

Understanding Iron Bisglycinate

Iron bisglycinate is a chelated form of iron that offers several advantages over traditional iron salts:

  • Higher bioavailability
  • Better gastrointestinal tolerance
  • Lower incidence of side effects

Dosing Recommendations

Adult Dosing:

  • Standard dose: 60-120 mg of elemental iron per day
  • Optimal administration: Single morning dose on alternate days
  • Maximum daily dose: Should not exceed 200 mg of elemental iron

Pediatric Dosing:

  • Children: 2-3 mg/kg/day of elemental iron 1
  • Maximum dose: 5 mg/day for routine supplementation 1

Administration Guidelines

Timing:

  • Preferred timing: Morning administration (single dose)
  • Avoid: Afternoon or evening dosing after a morning dose 2
  • Schedule: Alternate-day dosing is superior to daily dosing 3

Absorption Enhancement:

  • Take on an empty stomach if tolerated
  • Avoid taking within 2 hours before or 1 hour after meals 1
  • May be taken with vitamin C (ascorbic acid) to enhance absorption 2
  • Avoid taking with:
    • Calcium-containing foods or supplements
    • Tea or coffee
    • Antacids
    • Phosphate binders 1

Monitoring Response

  1. Initial assessment: Check hemoglobin after 14 days of therapy

    • A ≥1.0 g/dL increase indicates adequate response 4
    • If increase is <1.0 g/dL, consider switching to IV iron 4
  2. Follow-up monitoring:

    • Check hemoglobin every 4 weeks until normalization 5
    • Assess iron status (ferritin, transferrin saturation) after 8-10 weeks 5
    • Target ferritin >100 ng/mL and hemoglobin 11-12 g/dL 5

Special Considerations

For Patients with Poor Tolerance:

  • Start with lower doses (e.g., 60 mg elemental iron)
  • Consider alternate-day dosing to reduce side effects 3
  • If GI side effects persist, consider:
    • Taking with small amounts of food (though this may reduce absorption)
    • Switching to IV iron if oral therapy fails 5

For Patients with Ongoing Blood Loss:

  • Higher doses may be required
  • Consider IV iron therapy if losses exceed oral replacement capacity 5

For Patients with Chronic Kidney Disease:

  • Oral iron may be less effective due to hepcidin-mediated iron blockade
  • IV iron may be preferred in advanced CKD 1

Common Pitfalls to Avoid

  1. Overdosing: High doses don't improve absorption and increase side effects 2, 6
  2. Split dosing: Dividing doses throughout the day increases hepcidin and reduces absorption from subsequent doses 3
  3. Evening dosing: Circadian increases in hepcidin make evening doses less effective 2
  4. Continuing ineffective oral therapy: If no significant hemoglobin response after 14 days, consider IV iron 4
  5. Inadequate duration: Continue supplementation for 2-3 months after hemoglobin normalization to replenish iron stores 5

Evidence-Based Rationale

Recent research demonstrates that the traditional approach of high-dose, multiple daily iron supplementation is suboptimal. The body regulates iron absorption through hepcidin, which increases after iron ingestion and limits absorption of subsequent doses 3. Studies show that alternate-day dosing results in significantly higher fractional iron absorption (21.8% vs 16.3%) and total iron absorption (175.3 mg vs 131.0 mg) compared to consecutive-day dosing 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.